
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152537D88AF1D4A30537D80036C07F3A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="exhemaoncol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Experimental Hematology &amp; Oncology">
<meta name="citation_title" content="Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition">
<meta name="citation_author" content="Hayley M Sabol">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author" content="Aric Anloague">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author" content="Japneet Kaur">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author_institution" content="Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Cecile Bustamante-Gomez">
<meta name="citation_author_institution" content="Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Sharmin Khan">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author" content="Bethany C Paxton">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author" content="Mattie R Nester">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author" content="Jillian Hackney">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author" content="Marta Diaz-delCastillo">
<meta name="citation_author_institution" content="Forensic Medicine, University of Aarhus, Aarhus, Denmark">
<meta name="citation_author" content="Daniel Mann">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Jeffrey B Stambough">
<meta name="citation_author_institution" content="Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="C Lowry Barnes">
<meta name="citation_author_institution" content="Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Elena Ambrogini">
<meta name="citation_author_institution" content="Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Central Arkansas Veterans Healthcare System, Little Rock, AR USA">
<meta name="citation_author" content="Alison Frontier">
<meta name="citation_author_institution" content="Department of Chemistry, University of Rochester, Rochester, NY USA">
<meta name="citation_author" content="Frank H Ebetino">
<meta name="citation_author_institution" content="Department of Chemistry, University of Rochester, Rochester, NY USA">
<meta name="citation_author_institution" content="Biovinc LLC, Pasadena, CA USA">
<meta name="citation_author" content="Syed Naqvi">
<meta name="citation_author_institution" content="Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Frits van Rhee">
<meta name="citation_author_institution" content="Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Christopher P Wardell">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Matthew T Drake">
<meta name="citation_author_institution" content="Department of Internal Medicine, Mayo Clinic, Rochester, MN USA">
<meta name="citation_author" content="Intawat Nookaew">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author_institution" content="Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Carolina Schinke">
<meta name="citation_author_institution" content="Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Maurizio Zangari">
<meta name="citation_author_institution" content="Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author" content="Jesus Delgado-Calle">
<meta name="citation_author_institution" content="Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA">
<meta name="citation_author_institution" content="Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_author_institution" content="Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="14">
<meta name="citation_firstpage" content="108">
<meta name="citation_doi" content="10.1186/s40164-025-00699-4">
<meta name="citation_pmid" content="40847323">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/pdf/40164_2025_Article_699.pdf">
<meta name="description" content="Multiple myeloma (MM) is associated with a debilitating bone disease that poses significant therapeutic challenges. MM bone disease is characterized by increased bone resorption and suppression of osteoblasts, which hinders the repair of damaged ...">
<meta name="og:title" content="Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Multiple myeloma (MM) is associated with a debilitating bone disease that poses significant therapeutic challenges. MM bone disease is characterized by increased bone resorption and suppression of osteoblasts, which hinders the repair of damaged ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372396">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40164-025-00699-4"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40164_2025_Article_699.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372396%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372396/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372396/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-exhemaoncol.png" alt="Experimental Hematology &amp; Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Experimental Hematology &amp; Oncology" title="Link to Experimental Hematology &amp; Oncology" shape="default" href="https://ehoonline.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Exp Hematol Oncol</button></div>. 2025 Aug 22;14:108. doi: <a href="https://doi.org/10.1186/s40164-025-00699-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40164-025-00699-4</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Exp%20Hematol%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Exp%20Hematol%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Exp%20Hematol%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Exp%20Hematol%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sabol%20HM%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hayley M Sabol</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Hayley M Sabol</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sabol%20HM%22%5BAuthor%5D" class="usa-link"><span class="name western">Hayley M Sabol</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Anloague%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Aric Anloague</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Aric Anloague</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Anloague%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aric Anloague</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaur%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Japneet Kaur</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Japneet Kaur</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaur%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Japneet Kaur</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bustamante-Gomez%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Cecile Bustamante-Gomez</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Cecile Bustamante-Gomez</span></h3>
<div class="p">
<sup>3</sup>Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bustamante-Gomez%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cecile Bustamante-Gomez</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sharmin Khan</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sharmin Khan</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sharmin Khan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Paxton%20BC%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Bethany C Paxton</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Bethany C Paxton</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Paxton%20BC%22%5BAuthor%5D" class="usa-link"><span class="name western">Bethany C Paxton</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nester%20MR%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Mattie R Nester</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Mattie R Nester</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nester%20MR%22%5BAuthor%5D" class="usa-link"><span class="name western">Mattie R Nester</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hackney%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jillian Hackney</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jillian Hackney</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hackney%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jillian Hackney</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diaz-delCastillo%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Marta Diaz-delCastillo</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Marta Diaz-delCastillo</span></h3>
<div class="p">
<sup>4</sup>Forensic Medicine, University of Aarhus, Aarhus, Denmark </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diaz-delCastillo%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marta Diaz-delCastillo</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mann%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Daniel Mann</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Daniel Mann</span></h3>
<div class="p">
<sup>5</sup>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mann%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel Mann</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stambough%20JB%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Jeffrey B Stambough</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Jeffrey B Stambough</span></h3>
<div class="p">
<sup>6</sup>Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stambough%20JB%22%5BAuthor%5D" class="usa-link"><span class="name western">Jeffrey B Stambough</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barnes%20CL%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">C Lowry Barnes</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">C Lowry Barnes</span></h3>
<div class="p">
<sup>6</sup>Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barnes%20CL%22%5BAuthor%5D" class="usa-link"><span class="name western">C Lowry Barnes</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ambrogini%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Elena Ambrogini</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Elena Ambrogini</span></h3>
<div class="p">
<sup>3</sup>Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>7</sup>Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>8</sup>Central Arkansas Veterans Healthcare System, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ambrogini%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Ambrogini</span></a>
</div>
</div>
<sup>3,</sup><sup>7,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frontier%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Alison Frontier</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Alison Frontier</span></h3>
<div class="p">
<sup>9</sup>Department of Chemistry, University of Rochester, Rochester, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frontier%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alison Frontier</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ebetino%20FH%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Frank H Ebetino</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Frank H Ebetino</span></h3>
<div class="p">
<sup>9</sup>Department of Chemistry, University of Rochester, Rochester, NY USA </div>
<div class="p">
<sup>10</sup>Biovinc LLC, Pasadena, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ebetino%20FH%22%5BAuthor%5D" class="usa-link"><span class="name western">Frank H Ebetino</span></a>
</div>
</div>
<sup>9,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Naqvi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Syed Naqvi</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Syed Naqvi</span></h3>
<div class="p">
<sup>11</sup>Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Naqvi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Syed Naqvi</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Rhee%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Frits van Rhee</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Frits van Rhee</span></h3>
<div class="p">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>11</sup>Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Rhee%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Frits van Rhee</span></a>
</div>
</div>
<sup>2,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wardell%20CP%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Christopher P Wardell</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Christopher P Wardell</span></h3>
<div class="p">
<sup>5</sup>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>7</sup>Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wardell%20CP%22%5BAuthor%5D" class="usa-link"><span class="name western">Christopher P Wardell</span></a>
</div>
</div>
<sup>5,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Drake%20MT%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Matthew T Drake</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Matthew T Drake</span></h3>
<div class="p">
<sup>12</sup>Department of Internal Medicine, Mayo Clinic, Rochester, MN USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Drake%20MT%22%5BAuthor%5D" class="usa-link"><span class="name western">Matthew T Drake</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nookaew%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Intawat Nookaew</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Intawat Nookaew</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>5</sup>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>7</sup>Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nookaew%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Intawat Nookaew</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>5,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schinke%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Carolina Schinke</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Carolina Schinke</span></h3>
<div class="p">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>11</sup>Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schinke%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carolina Schinke</span></a>
</div>
</div>
<sup>2,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zangari%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Maurizio Zangari</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Maurizio Zangari</span></h3>
<div class="p">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>11</sup>Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zangari%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maurizio Zangari</span></a>
</div>
</div>
<sup>2,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delgado-Calle%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Jesus Delgado-Calle</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Jesus Delgado-Calle</span></h3>
<div class="p">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div class="p">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>6</sup>Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">
<sup>7</sup>Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delgado-Calle%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jesus Delgado-Calle</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>6,</sup><sup>7,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR USA </div>
<div id="Aff2">
<sup>2</sup>Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div id="Aff3">
<sup>3</sup>Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div id="Aff4">
<sup>4</sup>Forensic Medicine, University of Aarhus, Aarhus, Denmark </div>
<div id="Aff5">
<sup>5</sup>Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div id="Aff6">
<sup>6</sup>Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div id="Aff7">
<sup>7</sup>Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div id="Aff8">
<sup>8</sup>Central Arkansas Veterans Healthcare System, Little Rock, AR USA </div>
<div id="Aff9">
<sup>9</sup>Department of Chemistry, University of Rochester, Rochester, NY USA </div>
<div id="Aff10">
<sup>10</sup>Biovinc LLC, Pasadena, CA USA </div>
<div id="Aff11">
<sup>11</sup>Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR USA </div>
<div id="Aff12">
<sup>12</sup>Department of Internal Medicine, Mayo Clinic, Rochester, MN USA </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 31; Accepted 2025 Aug 12; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="https://creativecommons.org/publicdomain/zero/1.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372396Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847323/" class="usa-link">40847323</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Multiple myeloma (MM) is associated with a debilitating bone disease that poses significant therapeutic challenges. MM bone disease is characterized by increased bone resorption and suppression of osteoblasts, which hinders the repair of damaged bone. Sclerostin, an antagonist of Wnt signaling, is elevated in MM patients, and its inhibition with a neutralizing antibody (Scl-ab) has been shown to restore osteoblast function in mouse models of MM. However, it remains unclear whether Scl-ab can promote skeletal repair, enable effective tumor control when combined with anti-cancer agents, or improve bone health in MM patients.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">To investigate these knowledge gaps, we used preclinical MM mouse models and patient-derived samples. We also characterize the impact of Scl-ab on cancer and osteoblastic cells isolated from mouse models through bulk and single-cell RNA sequencing. Lastly, we performed a retrospective analysis of the efficacy of Scl-ab to improve bone health in patients with MM in remission.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Scl-ab promoted skeletal repair and enabled tumor suppression by an anti-cancer agent in various animal models of established MM bone disease. MM tumors suppressed Wnt signaling and decreased the number of osteoblasts and osteo-CAR cells, and treatment with Scl-ab reversed these effects. Treatment with Scl-ab increased bone mass and repaired bone in patients with MM in remission, even when combined with maintenance chemotherapy.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">Our findings highlight the potent bone-healing effects of Scl-ab and its potential as an adjuvant to anti-cancer therapy, offering a promising approach to improve clinical outcomes and the quality of life for MM patients.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s40164-025-00699-4.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Multiple myeloma, Wnt, Sclerostin, Bone, Lytic, Repair, Tumor</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par5">Multiple myeloma (MM) is the second most common hematologic cancer in the United States [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>], characterized by the clonal proliferation of malignant plasma cells within the bone marrow [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Bone disease is a hallmark of MM, affecting 80% of newly diagnosed patients [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>] and contributes significantly to morbidity and mortality [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Current therapies primarily target osteoclasts and reduce the risk of skeletal complications, but they do not repair damaged bone, which continues to deteriorate as the disease progresses [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Therefore, effective management of bone health is crucial to improving clinical outcomes in MM patients.</p>
<p id="Par6">MM-induced bone disease is shaped by interactions between tumor cells and cells of the bone marrow microenvironment, which support bone destruction by increasing osteoclasts and lead to the formation of debilitating lytic lesions [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. In addition, MM cells and cells of the tumor microenvironment secrete Wnt antagonists, such as Dkk1 [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>] and sclerostin [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>], which suppress osteoblast function and hinder bone repair, highlighting the need to restore osteoblast function to repair damaged bone in MM patients. Prior work has shown that blocking sclerostin with neutralizing antibodies (Scl-ab) restores osteoblast function and increases bone mass in MM mouse models [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], but the tumor growth persists unchecked. However, several critical questions remain regarding Scl-ab treatment in MM. These include whether it can heal lytic lesions and restore bone microarchitecture, the cellular and molecular mechanisms by which it promotes bone formation in the inhibitory MM niche, and its efficacy when used in conjunction with anti-tumor therapy. Moreover, although sclerostin levels are increased in MM patients, the effects of Scl-ab on bone health in these individuals remain unexplored.</p>
<p id="Par7">In this study, we show in preclinical MM models that romosozumab [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>], a clinically approved Scl-ab, repairs damaged bone, activates Wnt signaling and targets specific subpopulations of osteoblastic cells, and its bone anabolic efficacy is not affected when combined with anti-tumor therapy. Furthermore, we show for the first time that Scl-ab increases bone mass and repairs damaged bone in patients with MM in remission. The results from this study warrant further investigation to assess the potential of romosozumab as an adjunctive treatment to improve bone health in MM patients.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<p id="Par8">Here, we provide a brief description of the methods used; for more detailed information, please refer to the Supplementary Methods.</p>
<p id="Par9"><strong>Reagents.</strong> The bone-targeted GSI (BT-GSI) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>] is a conjugate formed by (i) a modified, less active bisphosphonate moiety with high bone affinity designed to direct the conjugate to the skeleton; (ii) a pH-sensitive labile linker that binds the cargo; and (iii) the cargo, the small molecule Î³-secretase inhibitor (GSI) XII that inhibits Notch signaling by preventing the cleavage of the Notch intracellular domain of Notch receptors. Detailed chemical steps for generating BT-GSI were described before [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<p id="Par10"><strong>Animal studies.</strong> 7-week-old immunocompetent C57BL/KaLwRijHsd (RRID: MGI:2164290) mice were injected intratibially with 1â€‰Ã—â€‰10<sup>5</sup> 5TGM1 MM cells or saline. After 4 weeks, mice were randomized by tumor burden and cancellous bone mass to groups (i) vehicle (saline), (ii) 100Â mg/kg; 1x/week Scl-ab (i.p.), (iii) 2.5Â mg/kg; 3x/week BT-GSI (i.p.), or (iv) Scl-abâ€‰+â€‰BT-GSI (combo) combined for 4 additional weeks. These dosing regimens were selected based on prior studies [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. 7-week-old immunodeficient NSG (RRID: IMSR_JAX:005557) mice were injected intravenously with 5â€‰Ã—â€‰10<sup>5</sup> OPM2-Luc<sup>+</sup> MM cells or saline. After one week, mice were randomized based on tumor burden and cancellous bone mass to groups (i) saline, (ii) Scl-ab, (iii) BT-GSI (i.p.), or (iv) combo combined for 3 additional weeks. To assess survival, the health of the mice was monitored daily, and mice were euthanized at the first signs of back leg paralysis. Toxicological studies are described in the Supplementary Materials.</p>
<p id="Par11">Ex vivo <strong>organ cultures.</strong> Ex vivo MM-human bone organ cultures were established using human cancellous bone fragments similar in size obtained from femoral heads discarded after hip arthroplasty, as described before [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Bone fragments and 2â€‰Ã—â€‰10<sup>5</sup> OPM2 MM cells were incubated for 24Â h. After 24Â h, bones with infiltrated MM cells were transferred to a new plate with fresh media and treated with vehicle, BT-GSI (10Â Î¼m), Scl-ab (15Â Î¼m), or a combination of BT-GSIâ€‰+â€‰Scl-ab. Treatments were refreshed every 3 days, and conditioned media was collected after 4 or 11 days. Flow cytometry studies are described in the Supplementary Materials.</p>
<p id="Par12"><strong>scRNA Sequencing.</strong> 7-week-old NSG mice were injected with 5â€‰Ã—â€‰10<sup>5</sup> OPM2 mCherry<sup>+</sup> MM cells, saline, or treated with Scl-ab (100Â mg/kg; 1x/week). After 2 weeks of treatment, a time point at which MM-induced bone loss and Scl-ab-induced bone anabolic effects are both evident, the muscle, periosteum, and epiphyses were removed from the tibias and femurs. The final dose of Scl-ab was administered 10Â h before tissue collection. The bones were cut longitudinally and processed to obtain osteoblastic cell populations, as reported before [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Cells from 2 to 4 mice per group were pooled, stained with DAPI (1ug/mL), and sorted using FACS to remove mCherry<sup>+</sup> MM cells or dead cells from the sample. Single-cell analysis was performed following our bioinformatic pipelines [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p>
<p id="Par13"><strong>Bulk RNA sequencing.</strong> 8-week-old immunocompetent C57BL/KaLwRijHsd mice were injected intravenously with 1â€‰Ã—â€‰10<sup>6</sup> GFP<sup>+</sup> 5TGM1 MM cells. After 2 weeks, mice were treated with vehicle, BT-GSI, Scl-ab, or BT-GSIâ€‰+â€‰Scl-ab. Mice were sacrificed after 3 weeks. The bone marrow from 3 long bones was flushed out, and RNA was obtained from MM cells isolated using CD138<sup>+</sup> microbeads (Miltenyi Biotec, cat #. 130-098-257). Preparation of RNA sequencing libraries (mRNA) and transcriptome sequencing was conducted by Novogene Co., LTD (San Jose, CA, USA).</p>
<p id="Par14"><strong>Human samples and histological analysis.</strong> Bone biopsies of 3-mm diameter from patients with MGUS or newly diagnosed MM (<em>n</em>â€‰=â€‰12â€“14) were retrieved from Danish histopathological biobanks and processed for RNA in situ hybridization as described before [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<p id="Par15"><strong>Patient population.</strong> This retrospective study involved patients with MM (<em>n</em>â€‰=â€‰5, 4/1 F/M, 71.8 years old (67â€“86)) in complete remission and with osteoporosis and a high risk of fracture, who received romosozumab (210Â mg monthly) therapy at the University of Arkansas for Medical Sciences (UAMS) (<em>n</em>â€‰=â€‰3) or the Mayo Clinic (<em>n</em>â€‰=â€‰2) for 12 months. Patients treated at UAMS had not received anti-resorptive therapy prior to romosozumab, whereas patients treated at the Mayo Clinic had received bisphosphonates, with the last dose administered 6 to 14 months before starting romosozumab. Contemporaneous UAMS MM patients in remission (<em>n</em>â€‰=â€‰10, 10/0 F/M, average 74 years old (64â€“83) who did not receive romosozumab and had available DXA (<em>n</em>â€‰=â€‰3) or PET-CT scans (<em>n</em>â€‰=â€‰10) with similar time intervals between scans served as control subjects. Nine of the ten control patients received bisphosphonates during the data collection. Medical records were accessed to gather data encompassing demographic information, baseline disease characteristics, therapies, PET-CT and DXA scans, and laboratory parameters. Disease remission was determined according to the International Myeloma Working Group (IMWG) criteria. Table S2 summarizes the patientsâ€™ characteristics. Femoral neck BMD measurements were made by DXA (Lunar Prodigy System; GE Healthcare). DXA scans were evaluated according to the International Society of Clinical Densitometry criteria (<a href="http://www.iscd.org/visitors/positions/OPReferences.cfm" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.iscd.org/visitors/positions/OPReferences.cfm</a>). PET-CT scans from multiple myeloma patients were retrieved and processed as described in the Supplementary Materials.</p>
<p id="Par16"><strong>Statistical analysis.</strong> Data were analyzed using GraphPad Prism (GraphPad Software, Inc., San Diego, CA, USA). Differences in means were analyzed using a combination of unpaired and paired <em>t</em>-test, One-Way ANOVA, and Two-Way ANOVA RM tests, followed by pairwise multiple comparisons (Tukey post hoc test). Values were reported as meansâ€‰Â±â€‰SD, unless otherwise indicated in the figure legends.</p></section><section id="Sec3"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec4"><h3 class="pmc_sec_title">Anti-sclerostin preserves the efficacy of anti-tumor therapy</h3>
<p id="Par17">Since Scl-ab does not affect tumor growth [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], we first evaluated the impact of co-administering Scl-ab on the efficacy of anti-cancer therapy in tumor progression. Human OPM2-Luciferase<sup>+</sup> MM cells, which harbor the t(4;14) translocation linked to poor prognosis, were injected into the tail vein of immunodeficient mice. After 1 week, mice were treated with a bone-targeted Notch inhibitor (BT-GSI), which has potent anti-MM effects [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>], or Scl-ab either as single agents or in combination (combo) for 3 weeks (Fig.Â <a href="#Fig1" class="usa-link">1</a>A). Mice receiving vehicle or Scl-ab showed a similar exponential increase in tumor growth, as indicated by elevated serum paraprotein levels (Figs.Â <a href="#Fig1" class="usa-link">1</a>B). In contrast, treatment with BT-GSI or the combo resulted in a similar 80% reduction in tumor burden compared to the vehicle-treated group and prolonged survival (Fig. <a href="#MOESM1" class="usa-link">S1</a>A-B). Similar tumor reductions were seen with quantitative assessment of bioluminescence in bone (Fig. <a href="#MOESM1" class="usa-link">S1</a>C-F). Of note, no changes in spleen weight were observed with any of the therapies (Fig. <a href="#MOESM1" class="usa-link">S1</a>G). Next, we injected 5TGM1 murine MM cells directly into the tibia of immunocompetent mice. After four weeks, treatment with BT-GSI, Scl-ab, or combo was initiated for an additional four weeks (Fig.Â <a href="#Fig1" class="usa-link">1</a>C). While Scl-ab alone did not impact tumor progression, both BT-GSI and combo significantly reduced tumor growth by 70% relative to the vehicle-treated group (Fig.Â <a href="#Fig1" class="usa-link">1</a>D), without significant changes in spleen weight (Fig. <a href="#MOESM1" class="usa-link">S1</a>H-I). Scl-ab induced a modest increase in glucose and a decrease in hemoglobin levels, but no other significant toxicities were observed when administered alone or in combination with BT-GSI (Table <a href="#MOESM1" class="usa-link">S1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/1c97e9449c9b/40164_2025_699_Fig1_HTML.jpg" loading="lazy" id="d33e737" height="1015" width="699" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Scl-ab enables suppression of tumor growth when co-administered with anti-cancer therapy in mice with established multiple myeloma. (<strong>A</strong>) Human xenograft mouse model experimental design. (<strong>B</strong>) Serum human lambda light chain paraprotein levels (meanâ€‰Â±â€‰SE). <em>n</em>â€‰=â€‰6â€“11 mice/group. (<strong>C</strong>) Immunocompetent mouse model experimental design. (<strong>D</strong>) Serum murine IgG2b paraprotein levels (meanâ€‰Â±â€‰SE). <em>n</em>â€‰=â€‰6â€“7 mice/group. Experimental design (<strong>E</strong>) and gene ontology (GO) enrichment analysis (<strong>F</strong>) in 5TGM1 MM cells isolated from mice receiving vehicle vs. Scl-ab. <em>n</em>â€‰=â€‰3 mice/group. (<strong>G</strong>) Ex vivo bone-MM organ cultures were established with bone fragments from a control subject and human OPM2 MM cells. (<strong>H</strong>) Percentage of mCherry<sup>+</sup> MM cells in human bone organ cultures treated with vehicle, BT-GSI, Scl-ab, or combo. <em>n</em>â€‰=â€‰5/group. *<em>p</em>â€‰&lt;â€‰0.05; **<em>p</em>â€‰&lt;â€‰0.01; ***<em>p</em>â€‰&lt;â€‰0.001 vs. MM-vehicle by Two-Way ANOVA RM (B - week 4, D - week 8) or by One-Way ANOVA (H). Rxâ€‰=â€‰treatment initiation; n.s.=non-significant</p></figcaption></figure><p id="Par19">To gain mechanistic insights into the effects of these treatments on tumor cells, we isolated CD138<sup>+</sup> 5TGM1 MM cells from the bone marrow of mice treated with veh, BT-GSI, Scl-ab, or combo for one week and performed bulk RNA-seq analysis (Fig.Â <a href="#Fig1" class="usa-link">1</a>E; Fig. <a href="#MOESM1" class="usa-link">S2A</a>-C). Treatment with BT-GSI (Fig. <a href="#MOESM1" class="usa-link">S3A</a>; Data file S1) or the combo (Fig. <a href="#MOESM1" class="usa-link">S3B</a>; Data file S2) led to the upregulation of apoptosis pathways and downregulation of cell cycle, DNA repair, and cell division biological processes, and downregulated the expression of Notch pathway targets and genes associated with cell proliferation in CD138<sup>+</sup> MM cells compared to MM cells from the vehicle group (Figs. <a href="#MOESM1" class="usa-link">S3C</a>-D). No significant changes were observed in apoptotic or cell cycle pathways or in the expression of Notch- or proliferation-related genes with Scl-ab (Fig.Â <a href="#Fig1" class="usa-link">1</a>F and Data file S3). To further investigate the anti-tumor efficacy of the Scl-ab in combination with anti-cancer therapy within a human bone microenvironment, we established ex vivo organ cultures using human bone specimens infiltrated with human OPM2 MM cells, a system that recapitulates the tumor microenvironment in patients [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>] (Fig.Â <a href="#Fig1" class="usa-link">1</a>G). In line with the findings in mouse models, Scl-ab did not affect the growth of MM cells. In contrast, BT-GSI alone or in combination with Scl-ab reduced the proportion of MM cells in bone by 50% compared to the vehicle group (Fig.Â <a href="#Fig1" class="usa-link">1</a>H).</p></section><section id="Sec5"><h3 class="pmc_sec_title">Anti-sclerostin treatment repairs damaged bone in MM</h3>
<p id="Par20">Next, we investigated the effects of Scl-ab on MM-induced bone disease in bones using the mouse models described above. We hypothesized that combining Scl-ab with anti-tumor therapy could, in addition to inhibiting tumor growth, concurrently reduce bone destruction and promote bone formation. To assess whether the Scl-ab therapy could repair damaged bone induced by MM tumors, we performed longitudinal in vivo micro CT imaging at multiple time points: baseline (before injections), before treatment (week 4), and after 4 weeks of treatment (week 8) in a murine model where 5TGM1 MM cells were injected intratibially (Fig.Â <a href="#Fig2" class="usa-link">2</a>A), an approach that allows tracking changes in bone mass and lytic lesions within each mouse over time. Mice receiving vehicle showed progressive bone loss (20% at week 4 and 50% at week 8; Fig.Â <a href="#Fig2" class="usa-link">2</a>B). Scl-ab restored bone mass to baseline levels and repaired lytic lesions (Figs.Â <a href="#Fig2" class="usa-link">2</a>B-D and Figs. S4A-C), improved key cancellous bone formation indexes to those seen in naÃ¯ve mice, and decreases cancellous osteoclast numbers/surface to control levels (Figs.Â <a href="#Fig2" class="usa-link">2</a>E-I and Figs. S4D-F). BT-GSI administered alone prevented further bone loss by inhibiting resorption, an effect due to the inhibitory actions of GSI on RANKL expression and osteoclast differentiation [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>], but did not improve bone mass or repair existing lytic lesions. The beneficial skeletal effects of Scl-ab were preserved when combined with anti-cancer therapy BT-GSI.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/a978558869ca/40164_2025_699_Fig2_HTML.jpg" loading="lazy" id="d33e854" height="686" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Scl-ab repairs damaged bone in immunocompetent mice with established MM-induced bone disease. (<strong>A</strong>) Immunocompetent mouse model experimental design. Quantification of tibiae (<strong>B</strong>) cancellous BV/TV, (<strong>C</strong>) cortical lytic lesions, and (<strong>D</strong>) representative microCT 3D reconstruction images before (week 4) and after (week 8) treatment, (<strong>E</strong>) bone formation rate in cancellous bone, (<strong>F</strong>) serum P1NP levels, (<strong>G</strong>) serum CTX levels, (<strong>H-I</strong>) osteoclasts number and surface in cancellous bone from immunocompetent mice injected intratibially with 5TGM1 MM cells and treated with veh, Scl-ab, BT-GSI or combo for 4 weeks. <em>n</em>â€‰=â€‰6â€“7 mice/group. BFR/BSâ€‰=â€‰bone formation rate per bone surface; Oc.N/BSâ€‰=â€‰osteoclast number per bone surface; Oc.S/BSâ€‰=â€‰osteoclast surface per bone surface. *<em>p</em>â€‰&lt;â€‰0.05; **<em>p</em>â€‰&lt;â€‰0.01; ***<em>p</em>â€‰&lt;â€‰0.001 vs. vehicle by paired t-Test (<strong>B</strong>-<strong>C</strong>) or One-Way ANOVA (<strong>E</strong>-<strong>I</strong>). The dotted line and orange color indicate basal (before MM injection) BV/TV meanâ€‰Â±â€‰SD values. Blue arrows and green squares indicate lytic lesions (<strong>D</strong>)</p></figcaption></figure><p id="Par22">MicroCT analysis revealed significant improvements in cancellous bone mass, trabecular number, thickness, and separation in the femurs and vertebrae and femoral cortical bone volume and thickness (Figs.Â <a href="#Fig3" class="usa-link">3</a>A-F and Figs. S5), and restoration of cancellous bone mass in the tibiae (Fig.Â <a href="#Fig3" class="usa-link">3</a>D) of immunodeficient mice bearing OPM2 MM cells treated with Scl-ab as a single agent. In this experiment, the combination treatment group exhibited higher cancellous bone mass compared to the group treated only with Scl-ab. While Scl-ab alone increased serum levels of P1NP and BT-GSI alone decreased the bone resorption marker CTX, the combination therapy resulted in a simultaneous increase in serum P1NP and a reduction in CTX (Figs.Â <a href="#Fig3" class="usa-link">3</a>G-H).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/0c0c42b372b9/40164_2025_699_Fig3_HTML.jpg" loading="lazy" id="d33e907" height="746" width="744" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Scl-ab improves bone health in a xenograft mouse model of established MM-induced bone disease. (<strong>A</strong>) Human xenograft mouse model experimental design. (<strong>B-C</strong>) Femur and L5 vertebrae bone volume/tissue volume (BV/TV, week 4), (<strong>D</strong>) representative microCT 3D reconstruction longitudinal images of tibiae cancellous BV/TV, (<strong>E-F</strong>) femur cortical (Ct) bone area/tissue area (BA/TA) and thickness, and (<strong>G-H</strong>) serum markers of bone formation P1NP and bone resorption CTX (week 4) from immunodeficient mice injected with human OPM2 MM cells in the tail vein and treated with vehicle, Scl-ab, BT-GSI, or combo for 3 weeks. <em>n</em>â€‰=â€‰6â€“11 mice/group. *<em>p</em>â€‰&lt;â€‰0.05; **<em>p</em>â€‰&lt;â€‰0.01; ***<em>p</em>â€‰&lt;â€‰0.001 vs. vehicle by One-Way ANOVA. Red squares indicate areas of bone repair (<strong>D</strong>)</p></figcaption></figure><p id="Par24">We further evaluated the effects of Scl-ab on human bone in ex vivo organ cultures (Fig.Â <a href="#Fig4" class="usa-link">4</a>A). Consistent with our in vivo observations, treatment with BT-GSI, with or without Scl-ab, significantly reduced the number of MM cells growing in bone organ cultures, while Scl-ab alone did not affect MM cell number (Fig.Â <a href="#Fig4" class="usa-link">4</a>B). After 14 days, MM cells significantly reduced P1NP and increased CTX levels in the culture media, downregulated the expression of the osteoblast marker <em>BGLAP</em>, and upregulated the expression of the pro-osteoclastogenic cytokine <em>RANKL</em> and the Notch target genes <em>HES1</em> and <em>HEY1</em> (Fig.Â <a href="#Fig4" class="usa-link">4</a>C-E). Scl-ab treatment increased P1NP levels and <em>BGLAP</em> expression but did not affect CTX or <em>RANKL/Notch</em> expression, which remained elevated compared to the control group. BT-GSI decreased CTX, <em>RANKL</em>, and Notch target genes compared to controls but did not affect P1NP or <em>BGLAP</em>, which remained decreased compared to controls. Remarkably, the combination therapy simultaneously increased P1NP and <em>BGLAP</em> levels while decreasing CTX, <em>RANKL</em>, and Notch gene expression (Figs.Â <a href="#Fig4" class="usa-link">4</a>C-E). Similar results were observed in bone tissue from a different donor (Fig. <a href="#MOESM1" class="usa-link">S6</a>). Together, these in vivo and ex vivo findings demonstrate that Scl-ab repairs damaged bone and improves bone health by enhancing bone formation, and that this bone protective effect is preserved when co-administered with anti-cancer therapy.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/bd693e25e0f2/40164_2025_699_Fig4_HTML.jpg" loading="lazy" id="d33e1011" height="444" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Impact of Scl-ab on human bones bearing human MM tumors cultured ex vivo. <strong>(A)</strong> Ex vivo bone-MM organ cultures were established using bone fragments from a control subject and human OPM2 MM cells and treated with vehicle, Scl-ab, or combo. Number of Cherryâ€‰+â€‰OPM2 MM cells (<strong>B</strong>), levels of P1NP <strong>(C)</strong> and CTX <strong>(D)</strong> in conditioned media, and <strong>(E)</strong> gene expression of <em>BGLAP</em>, <em>HES1</em>, <em>RANKL</em>, and <em>HEY1</em>. <em>n</em>â€‰=â€‰5 bones/group. *<em>p</em>â€‰&lt;â€‰0.05; **<em>p</em>â€‰&lt;â€‰0.01; ***<em>p</em>â€‰&lt;â€‰0.001vs. saline and #<em>p</em>â€‰&lt;â€‰0.05 vs. MM vehicle by One-way ANOVA</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">Scl-ab reverses the suppression of osteoblasts and osteo-CAR cells by MM tumors</h3>
<p id="Par26">Next, we utilized single-cell RNA sequencing to further characterize the impact of MM and Scl-ab on osteoblastic cells. Osteoblastic cells were isolated from the bones of naÃ¯ve mice, mice injected with human OPM2 MM cells, and naÃ¯ve mice treated with Scl-ab. We identified five distinct cellular clusters based on gene expression patterns: [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>] osteocytes [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], osteoblasts_1 [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>], osteoblasts_2 [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>], osteo-Cxcl12-abundant-reticular (CAR), and [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>] adipose-CARs (Figs. <a href="#MOESM1" class="usa-link">S7A</a>-C). MM cells led to a reduction of osteocyte, osteoblast_1, and osteo-CAR populations compared to naÃ¯ve mice, while no significant changes were observed in the adipo-CAR population (Fig.Â <a href="#Fig5" class="usa-link">5</a>A and S7D). Notably, our analysis also detected a unique subpopulation of â€œdiseasedâ€ osteoblasts (osteoblasts_2) that remained in the presence of tumors.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/15b79b42e81d/40164_2025_699_Fig5_HTML.jpg" loading="lazy" id="d33e1073" height="912" width="744" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Single-cell transcriptomic profiling identifies osteoblasts and osteo-CAR cells as targets of MM tumors. (<strong>A</strong>) Uniform Manifold Approximation and Projection (UMAP) plot representations of osteoblastic cells isolated from control (naÃ¯ve) or mice injected with human OPM2 MM cells in the tail vein showing five clusters: osteocytes (Ots), osteoblasts_1 (Obs_1), and osteoblasts_2 (Obs_2), osteo-CAR, and adipo-CAR cells. (<strong>B</strong>) Gene ontology (GO) enrichment analysis in downregulated genes expressed in osteoblastic cells from naÃ¯ve vs. MM mice. Bubble size is proportional to the enrichment p-value, and color intensity is proportional to enrichment. (<strong>C</strong>) Gene expression plot of downregulated genes in GO terms 001503 and 0030500 according to their relative abundance (log2 fold change) and statistical value (-log10 p-value) for each cell cluster in naÃ¯ve vs. MM mice. (<strong>D</strong>) Expression of <em>Lrp4</em>, <em>Lrp5</em>, and <em>Lrp6</em> in osteoblastic cells from naÃ¯ve vs. MM mice. Bubble size is proportional to the percentage of cells expressing the gene, and color intensity is proportional to the expression level of each cell type. (<strong>E</strong>) Downregulated pathways associated with Wnt signaling in osteoblastic cells from naÃ¯ve vs. MM mice. Bubble size is proportional to the enrichment p-value, and color intensity is proportional to the cell cluster</p></figcaption></figure><p id="Par28">Gene ontology analysis (see Data files S4-8 for top up/down GO terms and genes) of terms associated with bone biology revealed downregulation of pathways related to bone development and bone mineralization, with the most pronounced effects observed in osteoblasts_2 and osteo-CAR compared to adipo-CAR cells (Fig.Â <a href="#Fig5" class="usa-link">5</a>B). No major changes in these pathways were observed in osteocytes or osteoblast_1 populations, likely due to the low number of cells retrieved in the MM group. Both osteoblasts_2 and osteo-CARs exhibited consistent downregulation of key genes related to osteoblast differentiation and regulation of bone mineralization, while adipo-CARs or osteoblasts_1 were less affected by MM (Fig.Â <a href="#Fig5" class="usa-link">5</a>C). Furthermore, both populations of osteoblasts and osteo-CAR cells expressed higher levels of the sclerostin co-receptor <em>Lrp4</em> in naÃ¯ve mice (Fig.Â <a href="#Fig5" class="usa-link">5</a>D), which were upregulated by MM tumors in osteoblasts_1 and osteo-CARs, and decreased in osteoblast_2. Moreover, we noted the downregulation of Wnt-related gene ontology terms in osteoblasts_2 and, to a lesser extent, in osteo-CARs in the MM group (Fig.Â <a href="#Fig5" class="usa-link">5</a>E).</p>
<p id="Par29">Analysis of the Scl-ab scRNAseq dataset (Fig.Â <a href="#Fig6" class="usa-link">6</a>A; see Data files S9-13 for top up/down GO terms and genes) revealed upregulation of GO terms associated with Wnt signaling, cell proliferation, osteoblasts and chondrocyte differentiation, collagen formation, and skeletal development across the different cell clusters from Scl-ab treated mice compared to naÃ¯ve mice (Fig.Â <a href="#Fig6" class="usa-link">6</a>B). This upregulation was also seen in genes involved in osteoblast differentiation and the Wnt signaling pathway, particularly in osteo-CAR cells and osteoblasts_2, with more modest changes observed in adipo-CARs (Fig.Â <a href="#Fig6" class="usa-link">6</a>C). To further study the effects of MM and Scl-ab on osteoblastic cells, we quantified osteoblasts (<em>Bglap</em><sup>+</sup>) and osteo-CARs (<em>Limch</em>1<sup>+</sup>), which are primarily located at bone surfaces [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>], adipo-CARs (<em>Cxcl1</em>2+), which are mainly found within the bone marrow near sinusoidal blood vessels [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>], and MM cells (human <em>UBC</em>+) in the tumor microenvironment using a combination of gene expression markers and spatial location (Figs. <a href="#MOESM1" class="usa-link">S8A</a>-C). <em>Bglap</em><sup>+</sup> osteoblasts localized to bone surfaces and were decreased in the MM group but significantly increased in both naÃ¯ve mice and mice bearing MM tumors treated with Scl-ab (Figs.Â <a href="#Fig6" class="usa-link">6</a>D-E). <em>Limch1</em><sup>+</sup> osteo-CAR cells were found primarily on bone surfaces and a few in the bone marrow (Figs.Â <a href="#Fig6" class="usa-link">6</a>F-G). Similar to osteoblasts, osteo-CAR cells on bone surfaces were decreased by MM tumors and increased by Scl-ab treatment. Scl-ab only modestly increased <em>Limch1</em><sup>+</sup> cells located in the bone marrow (Fig. <a href="#MOESM1" class="usa-link">S6D</a>). <em>Cxcl12</em><sup>+</sup> adipo-CAR cells were preferentially located in the bone marrow and unaffected by MM tumors or Scl-ab (Figs.Â <a href="#Fig6" class="usa-link">6</a>H-I). Bones from mice with MM tumors had a higher prevalence of empty osteocyte lacunae compared to control mice, an observation that was not affected by Scl-ab treatment (Fig. <a href="#MOESM1" class="usa-link">S8E</a>). Together, our findings from scRNAseq analysis and spatial quantification highlight osteoblasts and osteo-CAR cells as the osteoblastic populations most susceptible to inhibition by MM cells and activation by Scl-ab.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/3c2496efd961/40164_2025_699_Fig6_HTML.jpg" loading="lazy" id="d33e1220" height="890" width="744" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Single-cell transcriptomic profiling shows that Scl-ab increases osteoblasts and osteo-CAR cells in the bone. (<strong>A</strong>) Uniform Manifold Approximation and Projection (UMAP) plot representations of osteoblastic cells isolated from naÃ¯ve and naÃ¯ve mice treated with anti-sclerostin-antibody (Scl-ab) showing 5 clusters: osteocytes (Ots), osteoblasts_1 (Obs_1), and osteoblasts_2 (Obs_2), osteo-CAR, and adipo-CAR cells. (<strong>B</strong>) Gene ontology (GO) enrichment analysis in upregulated genes expressed in osteoblastic cells from naÃ¯ve vs. Scl-ab-treated mice. Bubble size is proportional to the enrichment p-value, and color intensity is proportional to enrichment. (<strong>C</strong>) Gene expression plot of upregulated genes in GO terms 0001649 and 0060070 according to their relative abundance (log2 fold change) and statistical value (-log10 p-value) for each cell cluster in naÃ¯ve vs. Scl-ab treated mice. RNAscope representative images (<strong>D</strong>,<strong> F</strong>,<strong> H</strong>) and quantification (<strong>E</strong>,<strong> G</strong>,<strong> I</strong>) of <em>Bglap</em><sup>+</sup> cells on the bone surface, <em>Limch1</em><sup>+</sup> cells on the bone surface, and <em>Cxcl12</em><sup>+</sup> cells in the marrow from L4-6 vertebrae from control (naÃ¯ve), naÃ¯ve mice treated with Scl-ab, mice bearing human OPM2 MM cells receiving vehicle, or mice bearing murine OPM2 MM cells receiving Scl-ab. <em>n</em>â€‰=â€‰3â€“5 bones/group *<em>p</em>â€‰&lt;â€‰0.05; **<em>p</em>â€‰&lt;â€‰0.01 vs. naive by One-Way ANOVA</p></figcaption></figure></section><section id="Sec7"><h3 class="pmc_sec_title">Scl-ab improves bone health in patients with MM in remission</h3>
<p id="Par31">Prior work has demonstrated that MM cells reduce the number of viable osteocytes in both patients and animal models [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>], while also stimulating sclerostin production by osteocytes, though this has only been reported in preclinical models [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Sclerostin serum levels are increased in patients with MM [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>], but its production at the tissue levels has not been explored in MM patients. To address this gap, we examined sclerostin production in bone biopsies from patients with MM or MGUS, a precursor stage of the MM disease. Patients with MM exhibited a higher prevalence of cortical osteocytes expressing sclerostin compared to patients with MGUS (Figs.Â <a href="#Fig7" class="usa-link">7</a>A-B). We lastly assessed whether Scl-ab could improve bone health in MM patients. Towards this end, we retrospectively analyzed the effects of Scl-ab on bone mineral density (BMD) and tumor burden in 5 patients with MM who achieved complete remission. Table S2 summarizes the patientsâ€™ characteristics. Available positron emission tomography-computed tomography (PET-CT) and dual-energy X-ray absorptiometry (DXA) scans, along with serum paraprotein measurements, were used to assess bone health and tumor status. Patients with MM in remission who did not receive Scl-ab serve as controls. Notably, none of the patients receiving Scl-ab relapsed during treatment, as confirmed by PET-CT imaging and undetectable levels of M-protein (Table S2 and Figs. <a href="#MOESM1" class="usa-link">S9A</a>-B). Due to the retrospective nature of the study, we did not match cohorts of patients for the presence of osteoporosis, and MM patients receiving Scl-ab exhibited the lowest T-scores at baseline, before Scl-ab administration. Thus, we compared T-score changes within each individual, rather than absolute T-scores, for each group. All patients treated with Scl-ab exhibited an increase in BMD at the femoral neck, with T-scores rising between 0.3 and 1.4 after treatment (Fig.Â <a href="#Fig7" class="usa-link">7</a>C). To expand our analysis to other bone sites, we used AI-assisted segmentation [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>] to analyze bone density from CT scans taken before and after Scl-ab therapy (Fig.Â <a href="#Fig7" class="usa-link">7</a>D). This analysis revealed bone gain at multiple sites, including the femur, ribs, and spine (Fig.Â <a href="#Fig7" class="usa-link">7</a>E and Fig. <a href="#MOESM1" class="usa-link">S9C</a>). These gains were greater than those seen in controls, despite all the patients in the control group but one receiving anti-resorptive therapy (Fig.Â <a href="#Fig7" class="usa-link">7</a>C, Fig. <a href="#MOESM1" class="usa-link">S9C</a>, Table <a href="#MOESM1" class="usa-link">S2</a>). Moreover, significant repair of lytic lesions was observed in the skulls, vertebrae, pelvis, and femurs of MM patients receiving Scl-ab therapy (Figs.Â <a href="#Fig7" class="usa-link">7</a>F-I). While these clinical findings strongly suggest that Scl-ab therapy improves bone health in MM patients in remission, this retrospective analysis must be interpreted with caution due to the small sample size and patient and treatment heterogeneity.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372396_40164_2025_699_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e11a/12372396/76ee929163f6/40164_2025_699_Fig7_HTML.jpg" loading="lazy" id="d33e1352" height="954" width="744" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Anti-sclerostin-antibody effects on bone health in MM patients in remission. (<strong>A</strong>) Representative images of a bone biopsy from a patient with newly diagnosed MM and enlargement of the tissue section showing osteocytes positive for sclerostin (green), bone matrix protein osteopontin (yellow), and Hoechst-stained nuclei (blue). White arrows denote sclerostin<sup>+</sup> osteocytes. Scale bars, 2Â mm and 50Â Î¼m, respectively. (<strong>B</strong>) Percent of sclerostin<sup>+</sup> osteocytes in trabecular or cortical bone from patients with monoclonal gammopathy of undetermined significance (MGUS) or newly diagnosed MM. <em>n</em>â€‰=â€‰12â€“14 patients/group. *<em>p</em>â€‰&lt;â€‰0.05 vs. control by Studentâ€™s t-test. (<strong>C</strong>) Changes in femoral neck bone mineral density (BMD) T-scores during follow-up of patients with MM in remission treated with/without anti-sclerostin-antibody (Scl-ab). <em>n</em>â€‰=â€‰3â€“5 patients/group. Each dot represents an independent patient. (<strong>D</strong>) Experimental design to calculate radiodensity from PET-CT scans of patients with MM in remission treated with/without Scl-ab using the segmentation tool Skellytour. (<strong>E</strong>) Percent change in median radiodensity Hounsfield Units (HU) in femur, ribs, and spine from patients with MM in remission treated with/without Scl-ab. <em>n</em>â€‰=â€‰3â€“10 patients/group. *<em>p</em>â€‰&lt;â€‰0.05; **<em>p</em>â€‰&lt;â€‰0.01; ***<em>p</em>â€‰&lt;â€‰0.001 vs. control. Each dot represents an independent patient. Representative images of a healthy subject, a patient with MM in remission treated with Scl-ab (before and after), and a BMD gain heat map (before vs. after) showing improvements in bone health and bone repair in the skull (<strong>F</strong>), spine (<strong>G</strong>), pelvis (<strong>H</strong>), and femur (<strong>I</strong>). Scale bars, 5Â cm (<strong>F</strong>) and 25Â mm (<strong>G</strong>-<strong>I</strong>). â€œBeforeâ€ refers to PET-CT scans taken prior to the initiation of Scl-ab treatment, and â€œafterâ€ refers to those taken after the completion of the treatment course</p></figcaption></figure></section></section><section id="Sec8"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par33">In this study, we investigated several previously unknown aspects of reversing aberrant inhibition of Wnt signaling in the MM tumor microenvironment with Scl-ab. First, we demonstrate that neutralizing sclerostin preserves the efficacy of BT-GSI, an anti-tumor therapeutic agent. Second, we show that Scl-ab promotes bone repair and heals lytic lesions and identify specific subpopulations of osteoblastic lineage cells that respond to this treatment. Third, our retrospective analysis, though limited by sample size and patient heterogeneity, suggests that Scl-ab may improve bone health and promote bone repair in patients with MM in remission. Collectively, our findings provide evidence that Scl-Ab could significantly improve bone health in MM patients, offering a compelling rationale for conducting prospective, randomized trials to assess its long-term benefits and effects on disease progression and quality of life.</p>
<p id="Par34">Wnt signaling activation in MM cells has been shown to support tumor progression and contribute to the pathogenesis of MM [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. Due to its potential to stimulate tumor growth, caution has been exercised regarding the use of therapeutic agents that activate Wnt in the context of cancer. However, previous studies by us and others showed that Scl-ab does not affect tumor growth in animal models of MM [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. In this study, we confirmed that Scl-ab does not activate a transcriptional program in MM cells that leads to enhanced proliferation. However, our analysis showed other transcriptional changes induced by Scl-ab in MM cells. It is well established that osteoblastic lineage cells can influence MM cell transcriptome [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>], suggesting that the transcriptomic effects of Scl-ab in MM cells may involve indirect mechanisms through interactions with osteoblastic cells of the tumor niche. Yet, MM cells express the sclerostin co-receptor Lrp4 at the transcriptional level and thus could directly respond to sclerostin. We also showed that Wnt activation via Scl-ab does not promote MM growth in ex vivo organ cultures derived from human bone. Additionally, we observed that Scl-Ab did not cause disease relapse during the treatment course in five patients with MM who were in remission. However, this observation must be interpreted with caution due to the small sample size and the lack of extended follow-up, which limits our ability to exclude the possibility of delayed effects on disease progression. Importantly, Scl-ab does not interfere with the efficacy of BT-GSI or Carfilzomib, as shown before [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], in animal models. These results suggest that Scl-ab may be safely combined with other therapies, although further investigation into potential drug interactions is necessary.</p>
<p id="Par35">The mechanisms leading to osteoblast suppression in MM are complex. Previous work has primarily focused on the effects of MM cells on mesenchymal stem cells and osteoblasts in vitro [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Our scRNAseq study is among the first to investigate the impact of MM cells on various primary osteoblastic cells in vivo. We show that MM cells eliminate and reprogram osteoblastic cells, particularly osteoblasts and osteo-CAR cells, which exhibit Wnt signaling inhibition and suppression of genes involved in osteoblast differentiation and proliferation. Osteo-CAR cells have been recently proposed as a local source of osteoblast progenitors [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>] based on their close association with osteoblasts on the bone surface [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>] and the ability of CAR cells to differentiate into osteoblasts [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. We also identified a population of osteoblasts, osteoblast_2, that persisted in MM-bearing bones and expressed low levels of Lrp4, suggesting that these cells may be less susceptible to sclerostin-Lrp4 suppression. Further studies are warranted to investigate the characteristics of this population and its role in the progression of MM and bone disease. Lastly, we did not observe significant changes in the number of adipo-CAR cells, but this population displayed transcriptional reprogramming towards pro-angiogenesis.</p>
<p id="Par36">Our study is the first to show the capacity of Scl-ab to not only increase bone mass, as previously shown [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>], but also to promote the healing of osteolytic focal lesions in both animal models and patients. Notably, Scl-ab activates Wnt signaling and stimulates osteoblast differentiation and proliferation programs in both osteoblast and osteo-CAR cells in naÃ¯ve mice and restores these populations to control levels in mice bearing MM tumors, suggesting that sclerostin influences the function of these populations. It is important to note that our analysis was limited to osteoblastic lineage cells and did not include other bone marrow cell populations, such as immune cells, which may play a role in mediating the response to or could be influenced by Scl-ab. Moreover, whether the bone repair effects of Scl-ab are mediated through actions on osteoblasts or osteo-CARs, recovery of residual diseased osteoblasts (i.e., osteoblast_2 population), activation of lining or mesenchymal stem cells as shown in naÃ¯ve mice [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>], or a combination of these processes, remains uncertain and requires further study. Loss of Wnt/beta-catenin signaling is known to shift the cell fate of osteoprogenitors from osteoblasts to adipocytes [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. In our study, Scl-ab did not affect the number of adipo-CAR cells, which can differentiate into adipocytes [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. One possible explanation for this observation is the differential expression of Lrp4, which is significantly lower in adipo-CAR cells (Fig.Â <a href="#Fig5" class="usa-link">5</a>D). This reduced Lrp4 expression could make adipo-CAR cells less susceptible to Wnt signaling inhibition via sclerostin-Lrp4 signaling (Figs.Â <a href="#Fig6" class="usa-link">6</a>B-C). Additionally, it is possible that in MM, where marrow adipocytes are increased [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>], MM cells may influence adipo-CAR cells through Wnt-independent pathways, which could explain why the Adipo-CAR population remains unaffected by Scl-ab treatment.</p>
<p id="Par37">Co-administration of BHQ880, a neutralizing antibody against Dkk1, with anti-MM and anti-resorptive therapy, resulted in only modest improvements in bone health in a cohort of MM patients with relapsed/refractory disease [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. In our retrospective clinical study, romosozumab significantly improved bone health and repaired osteolytic lesions in patients with MM in remission (5/5-100%), with no evidence of disease relapse during the course of the treatment. Notably, patients treated with romosozumab experienced a greater increase in bone mass compared to the control group, even though the controls were receiving anti-resorptive therapy. These improvements are noteworthy, particularly given the severity of osteoporosis in these patients. Prior treatment with anti-resorptive has been shown to attenuate the bone anabolic effects of romosozumab [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Therefore, it is unlikely that the gains seen in the two patients from the Mayo Clinic were due to prior treatment with bisphosphonates. Romosozumab carries a black box warning for potential myocardial infarction or stroke in the preceding year. No cardiovascular events were reported in patients receiving romosozumab during this study. Although these results are promising, they should be interpreted with caution due to the limitations inherent in the retrospective design of the study, as well as the small sample size, lack of matching between cohorts, and patient and treatment heterogeneity. Moreover, the follow-up duration was insufficient to evaluate long-term fracture incidence and progression-free survival. Larger, prospective, randomized trials are needed to assess the long-term effects of romosozumab on skeletal-related events, quality of life in patients with MM, and disease progression. Of note, the beneficial skeletal impact of Scl-ab could be enhanced by the co-administration (as opposed to sequential treatment) of bisphosphonates and is not influenced by anti-cancer agents or chemotherapy, as demonstrated in both this and previous preclinical studies [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. These findings suggest that not only patients in remission but also patients at other stages of the disease, including those with MGUS who exhibit increased fracture risk [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>] or newly diagnosed MM patients, could benefit from romosozumab therapy. Lastly, bone remineralization and repair in MM remain an underexplored area due to the lack of proper analytic tools, and the regression of lytic lesions has only been reported in subsets of MM patients [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Our work also highlights the potential of AI-assisted imaging segmentation tools for evaluating bone health using CT scans, enabling consistent comparisons of the same anatomical site over time in MM patients.</p>
<p id="Par38">Proteasome inhibitors have bone anabolic effects in certain populations of MM patients, although these benefits may be transient [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. These agents stimulate osteoblast differentiation and bone-forming activity by preventing the proteasomal degradation of key osteogenic transcription factors, such as Runx2, thereby increasing the expression of bone-related genes, including osteocalcin and alkaline phosphatase [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Additionally, proteasome inhibitors promote osteocyte survival, particularly in the setting of MM and dexamethasone-induced apoptosis [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. They have also been shown to downregulate Dkk1 expression, which can help restore Wnt signaling and further support osteoblast function [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. These mechanisms of action differ from those of Scl-ab, which rely exclusively on the activation of Wnt signaling to enhance osteoblast and osteocyte survival and function [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Interestingly, in the two patients receiving VRd or lenalidomide maintenance therapy alongside romosozumab, we observed greater improvements in bone mineral density, suggesting potential additive beneficial effects on bone due to the anabolic and anti-resorptive properties of proteasome inhibitors and lenalidomide [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. This observation underscores the need for studies to determine the most effective combinatorial regimens for MM patients, particularly with regard to their effects on both bone health and tumor progression. Moreover, this study highlights the potential for exploring other bone anabolic agents in clinical practice, such as intermittent PTH or Dkk1-ab, which have been shown to exhibit bone anabolic potential in the context of MM [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>].</p></section><section id="Sec9"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par39">In conclusion, our findings provide new evidence supporting the use of Scl-ab to repair damaged bone and counteract the deleterious effects of MM in the skeleton. The combination of Scl-ab with anti-cancer therapeutics offers a unique combination of anti-cancer and bone anabolic effects, which are often not observed with current therapeutic regimens. Our data provide a strong and compelling rationale for conducting larger and prospective clinical trials in MM patients using romosozumab as an adjuvant.</p></section><section id="Sec10"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372396/bin/40164_2025_699_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (2.4MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors would like to acknowledge the services provided by the TBAPS of the UAMS Winthrop P. Rockefeller Cancer Institute, the Flow Cytometry Core (supported in part by the Center for Microbial Pathogenesis and Host Inflammatory Responses NIGMS P20GM103625), Genomics, Histology, and Microscopy Cores at UAMS. The authors thank Kaja Laursen (Aarhus University), Dr. Thomas Lund, and Dr. Maja Hinge (Odense University Hospital) for providing technical support and human bone biopsies, and Dr. Fumou Sun for assistance with i.v. injections.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>MM</dt>
<dd><p id="Par42">Multiple myeloma</p></dd>
<dt>Scl-ab</dt>
<dd><p id="Par43">Neutralizing antibody against sclerostin</p></dd>
<dt>CAR</dt>
<dd><p id="Par44">Cxcl12-abundant-reticular cell</p></dd>
<dt>BT-GSI</dt>
<dd><p id="Par45">Bone-targeted Notch inhibitor</p></dd>
<dt>GSI</dt>
<dd><p id="Par46">Gamma secretase inhibitor</p></dd>
<dt>PET-CT</dt>
<dd><p id="Par47">Positron emission tomography-computed tomography scan</p></dd>
<dt>DXA</dt>
<dd><p id="Par48">Dual-energy X-ray absorptiometry</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>C.S., M.Z., and J.D.C. conceived and supervised the project. H.M.S, M.D.D.C., C.S., and J.D.C. designed the experiments. H.M.S., A.A., J.K., C.B., S.K., B.C.P., M.R.N., J.H., M.D.D.C., D.M., J.B.S., C.L.B., E.A., A.F., F.H.E., C.W., M.T.D., I.N., C.S., and M.Z. performed the experiments and/or collected data. H.M.S., M.D.D.C., D.M., F.V.R., C.W., M.T.D., I.N., C.S., M.Z., and J.D.C. contributed to the data analysis and interpretation. J.D.C and H.M.S. wrote the manuscript. All authors reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the National Institutes of Health (NIH) R37CA251763, R01CA209882, R01CA241677 to J.D.C., P20GM125503 to J.D.C., I.N., and E.A., F31CA284655 to H.M.S., and <a href="https://www.ncbi.nlm.nih.gov/nuccore/AG075227" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">AG075227</a> to M.D.D.C., Neye Fonden and Aase og Ejnar Danielsens Fond to M.D.D.C. and the UAMS Winthrop P. Rockefeller Cancer Institute Voucher Program awarded to J.D.C.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The sc-RNA-seq and bulk RNAseq data generated in this study were deposited in the NCBI SRA database under the Bioproject PRJNA1210176 and PRJNA1211159. All other raw data are available upon request from the corresponding author.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar2"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par40">All procedures involving animals were performed in accordance with the guidelines issued by the University of Arkansas for Medical Sciences Institutional Animal Care and Use Committee (IACUC) (protocol #2022200000489). Collection and de-identification of human bone samples for ex vivo studies were coordinated by the UAMS Winthrop P. Rockefeller Cancer Institute TBAPS and approved by the UAMS IRB (protocol # 262940). All study procedures were approved by the University of Arkansas for Medical Sciences (IRB # 260312) and the Mayo Clinic (IRB # 23-012399) institutional review board with a waiver of informed consent owing to the retrospective nature of the data. Trephine iliac crest bone marrow biopsies from patients with MGUS or newly diagnosed MM were retrieved from Danish histopathological biobanks under approval from the Danish National Committee on Biomedical Research Ethics (S-20190110). All human samples were collected and processed in accordance with the Declaration of Helsinki.</p></section><section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par41">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisherâ€™s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Costa LJ, Brill IK, Omel J, Godby K, Kumar SK, Brown EE. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the united States. Blood Adv. 2017;1(4):282â€“7.
</cite> [<a href="https://doi.org/10.1182/bloodadvances.2016002493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5727774/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29296944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Costa%20LJ,%20Brill%20IK,%20Omel%20J,%20Godby%20K,%20Kumar%20SK,%20Brown%20EE.%20Recent%20trends%20in%20multiple%20myeloma%20incidence%20and%20survival%20by%20age,%20race,%20and%20ethnicity%20in%20the%20united%20States.%20Blood%20Adv.%202017;1(4):282%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410â€“27.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00135-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33516340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20de%20Donk%20N,%20Pawlyn%20C,%20Yong%20KL.%20Multiple%20myeloma.%20Lancet.%202021;397(10272):410%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Roodman GD. Pathogenesis of myeloma bone disease. Leukemia. 2009;23(3):435â€“41.
</cite> [<a href="https://doi.org/10.1038/leu.2008.336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19039321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roodman%20GD.%20Pathogenesis%20of%20myeloma%20bone%20disease.%20Leukemia.%202009;23(3):435%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Diaz-delCastillo M, Chantry AD, Lawson MA, Heegaard AM. Multiple myeloma-A painful disease of the bone marrow. Semin Cell Dev Biol. 2021;112:49â€“58.
</cite> [<a href="https://doi.org/10.1016/j.semcdb.2020.10.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33158730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Diaz-delCastillo%20M,%20Chantry%20AD,%20Lawson%20MA,%20Heegaard%20AM.%20Multiple%20myeloma-A%20painful%20disease%20of%20the%20bone%20marrow.%20Semin%20Cell%20Dev%20Biol.%202021;112:49%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Horsboel TA, Nielsen CV, Andersen NT, Nielsen B, de Thurah A. Risk of disability pension for patients diagnosed with haematological malignancies: a register-based cohort study. Acta Oncol. 2014;53(6):724â€“34.
</cite> [<a href="https://doi.org/10.3109/0284186X.2013.875625" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24456498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horsboel%20TA,%20Nielsen%20CV,%20Andersen%20NT,%20Nielsen%20B,%20de%20Thurah%20A.%20Risk%20of%20disability%20pension%20for%20patients%20diagnosed%20with%20haematological%20malignancies:%20a%20register-based%20cohort%20study.%20Acta%20Oncol.%202014;53(6):724%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Silbermann R, Roodman GD. Current controversies in the management of myeloma bone disease. J Cell Physiol. 2016;231(11):2374â€“9.
</cite> [<a href="https://doi.org/10.1002/jcp.25351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26910829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silbermann%20R,%20Roodman%20GD.%20Current%20controversies%20in%20the%20management%20of%20myeloma%20bone%20disease.%20J%20Cell%20Physiol.%202016;231(11):2374%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Silbermann R, Roodman GD. Bone effects of cancer therapies: pros and cons. Curr Opin Support Palliat Care. 2011;5(3):251â€“7.
</cite> [<a href="https://doi.org/10.1097/SPC.0b013e328349c524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21768880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silbermann%20R,%20Roodman%20GD.%20Bone%20effects%20of%20cancer%20therapies:%20pros%20and%20cons.%20Curr%20Opin%20Support%20Palliat%20Care.%202011;5(3):251%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Lomas OC, Tahri S, Ghobrial IM. The microenvironment in myeloma. Curr Opin Oncol. 2020;32(2):170â€“5.
</cite> [<a href="https://doi.org/10.1097/CCO.0000000000000615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31895122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lomas%20OC,%20Tahri%20S,%20Ghobrial%20IM.%20The%20microenvironment%20in%20myeloma.%20Curr%20Opin%20Oncol.%202020;32(2):170%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003;349(26):2483â€“94.
</cite> [<a href="https://doi.org/10.1056/NEJMoa030847" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14695408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20E,%20Zhan%20F,%20Walker%20R,%20Rasmussen%20E,%20Ma%20Y,%20Barlogie%20B,%20et%20al.%20The%20role%20of%20the%20Wnt-signaling%20antagonist%20DKK1%20in%20the%20development%20of%20osteolytic%20lesions%20in%20multiple%20myeloma.%20N%20Engl%20J%20Med.%202003;349(26):2483%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Delgado-Calle J, Anderson J, Cregor MD, Condon KW, Kuhstoss SA, Plotkin LI, et al. Genetic deletion of Sost or Pharmacological Inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth. Leukemia. 2017;31(12):2686â€“94.
</cite> [<a href="https://doi.org/10.1038/leu.2017.152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5699973/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28529307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Delgado-Calle%20J,%20Anderson%20J,%20Cregor%20MD,%20Condon%20KW,%20Kuhstoss%20SA,%20Plotkin%20LI,%20et%20al.%20Genetic%20deletion%20of%20Sost%20or%20Pharmacological%20Inhibition%20of%20sclerostin%20prevent%20multiple%20myeloma-induced%20bone%20disease%20without%20affecting%20tumor%20growth.%20Leukemia.%202017;31(12):2686%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Terpos E, Christoulas D, Katodritou E, Bratengeier C, Gkotzamanidou M, Michalis E, et al. Elevated Circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy. Int J Cancer. 2012;131(6):1466â€“71.
</cite> [<a href="https://doi.org/10.1002/ijc.27342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22052418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Terpos%20E,%20Christoulas%20D,%20Katodritou%20E,%20Bratengeier%20C,%20Gkotzamanidou%20M,%20Michalis%20E,%20et%20al.%20Elevated%20Circulating%20sclerostin%20correlates%20with%20advanced%20disease%20features%20and%20abnormal%20bone%20remodeling%20in%20symptomatic%20myeloma:%20reduction%20post-bortezomib%20monotherapy.%20Int%20J%20Cancer.%202012;131(6):1466%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>McDonald MM, Reagan MR, Youlten SE, Mohanty ST, Seckinger A, Terry RL, et al. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma. Blood. 2017;129(26):3452â€“64.
</cite> [<a href="https://doi.org/10.1182/blood-2017-03-773341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5492093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28515094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McDonald%20MM,%20Reagan%20MR,%20Youlten%20SE,%20Mohanty%20ST,%20Seckinger%20A,%20Terry%20RL,%20et%20al.%20Inhibiting%20the%20osteocyte-specific%20protein%20sclerostin%20increases%20bone%20mass%20and%20fracture%20resistance%20in%20multiple%20myeloma.%20Blood.%202017;129(26):3452%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Eda H, Santo L, Wein MN, Hu DZ, Cirstea DD, Nemani N, et al. Regulation of sclerostin expression in multiple myeloma by Dkk-1; A potential therapeutic strategy for myeloma bone disease. J Bone Min Res. 2016;31(6):1225â€“34.</cite> [<a href="https://doi.org/10.1002/jbmr.2789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5002355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26763740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eda%20H,%20Santo%20L,%20Wein%20MN,%20Hu%20DZ,%20Cirstea%20DD,%20Nemani%20N,%20et%20al.%20Regulation%20of%20sclerostin%20expression%20in%20multiple%20myeloma%20by%20Dkk-1;%20A%20potential%20therapeutic%20strategy%20for%20myeloma%20bone%20disease.%20J%20Bone%20Min%20Res.%202016;31(6):1225%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, ez-Perez A, et al. Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med. 2014;370(5):412â€“20.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1305224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24382002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McClung%20MR,%20Grauer%20A,%20Boonen%20S,%20Bolognese%20MA,%20Brown%20JP,%20ez-Perez%20A,%20et%20al.%20Romosozumab%20in%20postmenopausal%20women%20with%20low%20bone%20mineral%20density.%20N%20Engl%20J%20Med.%202014;370(5):412%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Sabol HM, Ferrari AJ, Adhikari M, Amorim T, McAndrews K, Anderson J, et al. Targeting Notch inhibitors to the myeloma bone marrow niche decreases tumor growth and bone destruction without gut toxicity. Cancer Res. 2021;81(19):5102â€“14.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-21-0524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8488008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34348968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sabol%20HM,%20Ferrari%20AJ,%20Adhikari%20M,%20Amorim%20T,%20McAndrews%20K,%20Anderson%20J,%20et%20al.%20Targeting%20Notch%20inhibitors%20to%20the%20myeloma%20bone%20marrow%20niche%20decreases%20tumor%20growth%20and%20bone%20destruction%20without%20gut%20toxicity.%20Cancer%20Res.%202021;81(19):5102%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Ominsky MS, Boyce RW, Li X, Ke HZ. Effects of sclerostin antibodies in animal models of osteoporosis. Bone. 2017;96:63â€“75.
</cite> [<a href="https://doi.org/10.1016/j.bone.2016.10.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27789417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ominsky%20MS,%20Boyce%20RW,%20Li%20X,%20Ke%20HZ.%20Effects%20of%20sclerostin%20antibodies%20in%20animal%20models%20of%20osteoporosis.%20Bone.%202017;96:63%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Sabol HM, Ashby C, Adhikari M, Anloague A, Kaur J, Khan S et al. A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma. Haematologica. 2024;109(8):2606-18. </cite> [<a href="https://doi.org/10.3324/haematol.2023.284443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11290536/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38385272/" class="usa-link">PubMed</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Kaur J, Adhikari M, Sabol HM, Anloague A, Khan S, Kurihara N, et al. Single-Cell transcriptomic analysis identifies senescent osteocytes that trigger bone destruction in breast cancer metastasis. Cancer Res. 2024;84(23):3936â€“52.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-24-0857" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11611663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39312185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaur%20J,%20Adhikari%20M,%20Sabol%20HM,%20Anloague%20A,%20Khan%20S,%20Kurihara%20N,%20et%20al.%20Single-Cell%20transcriptomic%20analysis%20identifies%20senescent%20osteocytes%20that%20trigger%20bone%20destruction%20in%20breast%20cancer%20metastasis.%20Cancer%20Res.%202024;84(23):3936%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Nookaew I, Xiong J, Onal M, Bustamante-Gomez C, Wanchai V, Fu Q, et al. Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone. J Biol Chem. 2024;300(4):107158.
</cite> [<a href="https://doi.org/10.1016/j.jbc.2024.107158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11007436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38479598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nookaew%20I,%20Xiong%20J,%20Onal%20M,%20Bustamante-Gomez%20C,%20Wanchai%20V,%20Fu%20Q,%20et%20al.%20Refining%20the%20identity%20of%20mesenchymal%20cell%20types%20associated%20with%20murine%20periosteal%20and%20endosteal%20bone.%20J%20Biol%20Chem.%202024;300(4):107158." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Nookaew I, Papini M, Pornputtapong N, Scalcinati G, Fagerberg L, UhlÃ©n M, et al. A comprehensive comparison of RNA-Seq-based transcriptome analysis from reads to differential gene expression and cross-comparison with microarrays: a case study in Saccharomyces cerevisiae. Nucleic Acids Res. 2012;40(20):10084â€“97.
</cite> [<a href="https://doi.org/10.1093/nar/gks804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3488244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22965124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nookaew%20I,%20Papini%20M,%20Pornputtapong%20N,%20Scalcinati%20G,%20Fagerberg%20L,%20Uhl%C3%A9n%20M,%20et%20al.%20A%20comprehensive%20comparison%20of%20RNA-Seq-based%20transcriptome%20analysis%20from%20reads%20to%20differential%20gene%20expression%20and%20cross-comparison%20with%20microarrays:%20a%20case%20study%20in%20Saccharomyces%20cerevisiae.%20Nucleic%20Acids%20Res.%202012;40(20):10084%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Bellido T, Delgado-Calle J. Ex vivo organ cultures as models to study bone biology. JBMR Plus. 2020;4(3) 10.1002/jbm4.10345</cite> [<a href="https://doi.org/10.1002/jbm4.10345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7059827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32161838/" class="usa-link">PubMed</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Matsushita Y, Ono W, Ono N. Toward marrow adipocytes: adipogenic trajectory of the bone marrow stromal cell lineage. Front Endocrinol (Lausanne). 2022;13:882297.
</cite> [<a href="https://doi.org/10.3389/fendo.2022.882297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9075612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35528017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matsushita%20Y,%20Ono%20W,%20Ono%20N.%20Toward%20marrow%20adipocytes:%20adipogenic%20trajectory%20of%20the%20bone%20marrow%20stromal%20cell%20lineage.%20Front%20Endocrinol%20(Lausanne).%202022;13:882297." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Giuliani N, Ferretti M, Bolzoni M, Storti P, Lazzaretti M, Dalla PB, et al. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation. Leukemia. 2012;26(6):1391â€“401.
</cite> [<a href="https://doi.org/10.1038/leu.2011.381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22289923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giuliani%20N,%20Ferretti%20M,%20Bolzoni%20M,%20Storti%20P,%20Lazzaretti%20M,%20Dalla%20PB,%20et%20al.%20Increased%20osteocyte%20death%20in%20multiple%20myeloma%20patients:%20role%20in%20myeloma-induced%20osteoclast%20formation.%20Leukemia.%202012;26(6):1391%E2%80%93401." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Delgado-Calle J, Anderson J, Cregor MD, Hiasa M, Chirgwin JM, Carlesso N, et al. Bidirectional Notch signaling and Osteocyte-Derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma. Cancer Res. 2016;76(5):1089â€“100.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-15-1703" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4775415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26833121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Delgado-Calle%20J,%20Anderson%20J,%20Cregor%20MD,%20Hiasa%20M,%20Chirgwin%20JM,%20Carlesso%20N,%20et%20al.%20Bidirectional%20Notch%20signaling%20and%20Osteocyte-Derived%20factors%20in%20the%20bone%20marrow%20microenvironment%20promote%20tumor%20cell%20proliferation%20and%20bone%20destruction%20in%20multiple%20myeloma.%20Cancer%20Res.%202016;76(5):1089%E2%80%93100." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Mann DCR, Farmer M, Eichhorn P, Manzil J, Wardell C.P. Evaluating Skellytour for automated skeleton segmentation from Whole-Body CT images. Radiology: Artificial Intelligence. 2025;.</cite> [<a href="https://doi.org/10.1148/ryai.240050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11950879/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39969277/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>van Andel H, Kocemba KA, Spaargaren M, Pals ST. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia. 2019;33(5):1063â€“75.
</cite> [<a href="https://doi.org/10.1038/s41375-019-0404-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6756057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30770859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Andel%20H,%20Kocemba%20KA,%20Spaargaren%20M,%20Pals%20ST.%20Aberrant%20Wnt%20signaling%20in%20multiple%20myeloma:%20molecular%20mechanisms%20and%20targeting%20options.%20Leukemia.%202019;33(5):1063%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Binder M, Szalat RE, Talluri S, Fulciniti M, Avet-Loiseau H, Parmigiani G, et al. Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes. Nat Commun. 2024;15(1):4139.
</cite> [<a href="https://doi.org/10.1038/s41467-024-47793-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11098817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38755155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Binder%20M,%20Szalat%20RE,%20Talluri%20S,%20Fulciniti%20M,%20Avet-Loiseau%20H,%20Parmigiani%20G,%20et%20al.%20Bone%20marrow%20stromal%20cells%20induce%20chromatin%20remodeling%20in%20multiple%20myeloma%20cells%20leading%20to%20transcriptional%20changes.%20Nat%20Commun.%202024;15(1):4139." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Adamik J, Galson DL, Roodman GD. Osteoblast suppression in multiple myeloma bone disease. J Bone Oncol. 2018;13:62â€“70.
</cite> [<a href="https://doi.org/10.1016/j.jbo.2018.09.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6303385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30591859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adamik%20J,%20Galson%20DL,%20Roodman%20GD.%20Osteoblast%20suppression%20in%20multiple%20myeloma%20bone%20disease.%20J%20Bone%20Oncol.%202018;13:62%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Matsushita Y, Liu J, Chu AKY, Tsutsumi-Arai C, Nagata M, Arai Y, et al. Bone marrow endosteal stem cells dictate active osteogenesis and aggressive tumorigenesis. Nat Commun. 2023;14(1):2383.
</cite> [<a href="https://doi.org/10.1038/s41467-023-38034-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10130060/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37185464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matsushita%20Y,%20Liu%20J,%20Chu%20AKY,%20Tsutsumi-Arai%20C,%20Nagata%20M,%20Arai%20Y,%20et%20al.%20Bone%20marrow%20endosteal%20stem%20cells%20dictate%20active%20osteogenesis%20and%20aggressive%20tumorigenesis.%20Nat%20Commun.%202023;14(1):2383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Baccin C, Al-Sabah J, Velten L, Helbling PM, GrÃ¼nschlÃ¤ger F, HernÃ¡ndez-Malmierca P, et al. Combined single-cell and Spatial transcriptomics reveal the molecular, cellular and Spatial bone marrow niche organization. Nat Cell Biol. 2020;22(1):38â€“48.
</cite> [<a href="https://doi.org/10.1038/s41556-019-0439-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7610809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31871321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baccin%20C,%20Al-Sabah%20J,%20Velten%20L,%20Helbling%20PM,%20Gr%C3%BCnschl%C3%A4ger%20F,%20Hern%C3%A1ndez-Malmierca%20P,%20et%20al.%20Combined%20single-cell%20and%20Spatial%20transcriptomics%20reveal%20the%20molecular,%20cellular%20and%20Spatial%20bone%20marrow%20niche%20organization.%20Nat%20Cell%20Biol.%202020;22(1):38%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Kim SW, Lu Y, Williams EA, Lai F, Lee JY, Enishi T, et al. Sclerostin antibody administration converts bone lining cells into active osteoblasts. J Bone Min Res. 2016;32(5):892â€“901.</cite> [<a href="https://doi.org/10.1002/jbmr.3038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5413385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27862326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20SW,%20Lu%20Y,%20Williams%20EA,%20Lai%20F,%20Lee%20JY,%20Enishi%20T,%20et%20al.%20Sclerostin%20antibody%20administration%20converts%20bone%20lining%20cells%20into%20active%20osteoblasts.%20J%20Bone%20Min%20Res.%202016;32(5):892%E2%80%93901." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Ominsky MS, Brown DL, Van G, Cordover D, Pacheco E, Frazier E, et al. Differential Temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats. Bone. 2015;81:380â€“91.
</cite> [<a href="https://doi.org/10.1016/j.bone.2015.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26261096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ominsky%20MS,%20Brown%20DL,%20Van%20G,%20Cordover%20D,%20Pacheco%20E,%20Frazier%20E,%20et%20al.%20Differential%20Temporal%20effects%20of%20sclerostin%20antibody%20and%20parathyroid%20hormone%20on%20cancellous%20and%20cortical%20bone%20and%20quantitative%20differences%20in%20effects%20on%20the%20osteoblast%20lineage%20in%20young%20intact%20rats.%20Bone.%202015;81:380%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Song L, Liu M, Ono N, Bringhurst FR, Kronenberg HM, Guo J. Loss of wnt/Î²-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes. J Bone Min Res. 2012;27(11):2344â€“58.</cite> [<a href="https://doi.org/10.1002/jbmr.1694" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3474875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22729939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20L,%20Liu%20M,%20Ono%20N,%20Bringhurst%20FR,%20Kronenberg%20HM,%20Guo%20J.%20Loss%20of%20wnt/%CE%B2-catenin%20signaling%20causes%20cell%20fate%20shift%20of%20preosteoblasts%20from%20osteoblasts%20to%20adipocytes.%20J%20Bone%20Min%20Res.%202012;27(11):2344%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Morris EV, Edwards CM. Bone marrow adiposity and multiple myeloma. Bone. 2019;118:42â€“6.
</cite> [<a href="https://doi.org/10.1016/j.bone.2018.03.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29548987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morris%20EV,%20Edwards%20CM.%20Bone%20marrow%20adiposity%20and%20multiple%20myeloma.%20Bone.%202019;118:42%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Iyer SP, Beck JT, Stewart AK, Shah J, Kelly KR, Isaacs R, et al. A phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and Zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. Br J Haematol. 2014;167(3):366â€“75.
</cite> [<a href="https://doi.org/10.1111/bjh.13056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25139740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iyer%20SP,%20Beck%20JT,%20Stewart%20AK,%20Shah%20J,%20Kelly%20KR,%20Isaacs%20R,%20et%20al.%20A%20phase%20IB%20multicentre%20dose-determination%20study%20of%20BHQ880%20in%20combination%20with%20anti-myeloma%20therapy%20and%20Zoledronic%20acid%20in%20patients%20with%20relapsed%20or%20refractory%20multiple%20myeloma%20and%20prior%20skeletal-related%20events.%20Br%20J%20Haematol.%202014;167(3):366%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, et al. Romosozumab and antiresorptive treatment: the importance of treatment sequence. Osteoporos Int. 2022;33(6):1243â€“56.
</cite> [<a href="https://doi.org/10.1007/s00198-021-06174-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9106644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35165774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cosman%20F,%20Kendler%20DL,%20Langdahl%20BL,%20Leder%20BZ,%20Lewiecki%20EM,%20Miyauchi%20A,%20et%20al.%20Romosozumab%20and%20antiresorptive%20treatment:%20the%20importance%20of%20treatment%20sequence.%20Osteoporos%20Int.%202022;33(6):1243%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>McClung MR, Bolognese MA, Brown JP, Reginster JY, Langdahl BL, Shi Y, et al. Skeletal responses to Romosozumab after 12 months of denosumab. JBMR Plus. 2021;5(7):e10512.
</cite> [<a href="https://doi.org/10.1002/jbm4.10512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8260819/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34258507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McClung%20MR,%20Bolognese%20MA,%20Brown%20JP,%20Reginster%20JY,%20Langdahl%20BL,%20Shi%20Y,%20et%20al.%20Skeletal%20responses%20to%20Romosozumab%20after%2012%20months%20of%20denosumab.%20JBMR%20Plus.%202021;5(7):e10512." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Farr JN, Zhang W, Kumar SK, Jacques RM, Ng AC, McCready LK, et al. Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance. Blood. 2014;123(5):647â€“9.
</cite> [<a href="https://doi.org/10.1182/blood-2013-05-505776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3907752/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24227822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Farr%20JN,%20Zhang%20W,%20Kumar%20SK,%20Jacques%20RM,%20Ng%20AC,%20McCready%20LK,%20et%20al.%20Altered%20cortical%20microarchitecture%20in%20patients%20with%20monoclonal%20gammopathy%20of%20undetermined%20significance.%20Blood.%202014;123(5):647%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Mohan M, Kumar M, Samant R, Van Hemert R Jr., Tian E, Desai S, et al. Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience. Bone. 2021;146:115876.
</cite> [<a href="https://doi.org/10.1016/j.bone.2021.115876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8627246/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33556629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mohan%20M,%20Kumar%20M,%20Samant%20R,%20Van%20Hemert%20R%20Jr.,%20Tian%20E,%20Desai%20S,%20et%20al.%20Bone%20remineralization%20of%20lytic%20lesions%20in%20multiple%20myeloma%20-%20The%20Arkansas%20experience.%20Bone.%202021;146:115876." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Zangari M, Terpos E, Zhan F, Tricot G. Impact of bortezomib on bone health in myeloma: a review of current evidence. Cancer Treat Rev. 2012;38(8):968â€“80.
</cite> [<a href="https://doi.org/10.1016/j.ctrv.2011.12.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22226939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zangari%20M,%20Terpos%20E,%20Zhan%20F,%20Tricot%20G.%20Impact%20of%20bortezomib%20on%20bone%20health%20in%20myeloma:%20a%20review%20of%20current%20evidence.%20Cancer%20Treat%20Rev.%202012;38(8):968%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Zangari M, Esseltine D, Lee CK, Barlogie B, Elice F, Burns MJ, et al. Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma. Br J Haematol. 2005;131(1):71â€“3.
</cite> [<a href="https://doi.org/10.1111/j.1365-2141.2005.05733.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16173965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zangari%20M,%20Esseltine%20D,%20Lee%20CK,%20Barlogie%20B,%20Elice%20F,%20Burns%20MJ,%20et%20al.%20Response%20to%20bortezomib%20is%20associated%20to%20osteoblastic%20activation%20in%20patients%20with%20multiple%20myeloma.%20Br%20J%20Haematol.%202005;131(1):71%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Haidl F, Plesner T, Lund T. Treatment with bortezomib in multiple myeloma is associated with only a transient and brief increase of bone specific alkaline phosphatase. Leuk Res. 2012;36(10):1296â€“9.
</cite> [<a href="https://doi.org/10.1016/j.leukres.2012.06.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22748823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haidl%20F,%20Plesner%20T,%20Lund%20T.%20Treatment%20with%20bortezomib%20in%20multiple%20myeloma%20is%20associated%20with%20only%20a%20transient%20and%20brief%20increase%20of%20bone%20specific%20alkaline%20phosphatase.%20Leuk%20Res.%202012;36(10):1296%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Giuliani N, Morandi F, Tagliaferri S, Lazzaretti M, Bonomini S, Crugnola M, et al. The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients. Blood. 2007;110(1):334â€“8.
</cite> [<a href="https://doi.org/10.1182/blood-2006-11-059188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17371942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giuliani%20N,%20Morandi%20F,%20Tagliaferri%20S,%20Lazzaretti%20M,%20Bonomini%20S,%20Crugnola%20M,%20et%20al.%20The%20proteasome%20inhibitor%20bortezomib%20affects%20osteoblast%20differentiation%20in%20vitro%20and%20in%20vivo%20in%20multiple%20myeloma%20patients.%20Blood.%202007;110(1):334%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Accardi F, Toscani D, Costa F, Aversa F, Giuliani N. The proteasome and Myeloma-Associated bone disease. Calcif Tissue Int. 2018;102(2):210â€“26.
</cite> [<a href="https://doi.org/10.1007/s00223-017-0349-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29080972/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Accardi%20F,%20Toscani%20D,%20Costa%20F,%20Aversa%20F,%20Giuliani%20N.%20The%20proteasome%20and%20Myeloma-Associated%20bone%20disease.%20Calcif%20Tissue%20Int.%202018;102(2):210%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Toscani D, Palumbo C, Dalla PB, Ferretti M, Bolzoni M, Marchica V, et al. The proteasome inhibitor bortezomib maintains osteocyte viability in multiple myeloma patients by reducing both apoptosis and autophagy: A new function for proteasome inhibitors. J Bone Min Res. 2016;31(4):815â€“27.</cite> [<a href="https://doi.org/10.1002/jbmr.2741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26551485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Toscani%20D,%20Palumbo%20C,%20Dalla%20PB,%20Ferretti%20M,%20Bolzoni%20M,%20Marchica%20V,%20et%20al.%20The%20proteasome%20inhibitor%20bortezomib%20maintains%20osteocyte%20viability%20in%20multiple%20myeloma%20patients%20by%20reducing%20both%20apoptosis%20and%20autophagy:%20A%20new%20function%20for%20proteasome%20inhibitors.%20J%20Bone%20Min%20Res.%202016;31(4):815%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Uyama M, Sato MM, Kawanami M, Tamura M. Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib. Genes Cells. 2012;17(7):548â€“58.
</cite> [<a href="https://doi.org/10.1111/j.1365-2443.2012.01611.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22702336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Uyama%20M,%20Sato%20MM,%20Kawanami%20M,%20Tamura%20M.%20Regulation%20of%20osteoblastic%20differentiation%20by%20the%20proteasome%20inhibitor%20bortezomib.%20Genes%20Cells.%202012;17(7):548%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Delgado-Calle J, Sato AY, Bellido T. Role and mechanism of action of sclerostin in bone. Bone. 2017;96:29â€“37.
</cite> [<a href="https://doi.org/10.1016/j.bone.2016.10.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5328835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27742498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Delgado-Calle%20J,%20Sato%20AY,%20Bellido%20T.%20Role%20and%20mechanism%20of%20action%20of%20sclerostin%20in%20bone.%20Bone.%202017;96:29%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Baron R, Rawadi G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007;148(6):2635â€“43.
</cite> [<a href="https://doi.org/10.1210/en.2007-0270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17395698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baron%20R,%20Rawadi%20G.%20Targeting%20the%20Wnt/beta-catenin%20pathway%20to%20regulate%20bone%20formation%20in%20the%20adult%20skeleton.%20Endocrinology.%202007;148(6):2635%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Terpos E, Christoulas D, Kastritis E, Katodritou E, Papatheodorou A, Pouli A, et al. The combination of Lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study group. Am J Hematol. 2014;89(1):34â€“40.
</cite> [<a href="https://doi.org/10.1002/ajh.23577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23983166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Terpos%20E,%20Christoulas%20D,%20Kastritis%20E,%20Katodritou%20E,%20Papatheodorou%20A,%20Pouli%20A,%20et%20al.%20The%20combination%20of%20Lenalidomide%20and%20dexamethasone%20reduces%20bone%20resorption%20in%20responding%20patients%20with%20relapsed/refractory%20multiple%20myeloma%20but%20has%20no%20effect%20on%20bone%20formation:%20final%20results%20on%20205%20patients%20of%20the%20Greek%20myeloma%20study%20group.%20Am%20J%20Hematol.%202014;89(1):34%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Pennisi A, Ling W, Li X, Khan S, Wang Y, Barlogie B, et al. Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone. PLoS ONE. 2010;5(12):e15233.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0015233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3004797/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21188144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pennisi%20A,%20Ling%20W,%20Li%20X,%20Khan%20S,%20Wang%20Y,%20Barlogie%20B,%20et%20al.%20Consequences%20of%20daily%20administered%20parathyroid%20hormone%20on%20myeloma%20growth,%20bone%20disease,%20and%20molecular%20profiling%20of%20whole%20myelomatous%20bone.%20PLoS%20ONE.%202010;5(12):e15233." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Heath DJ, Chantry AD, Buckle CH, Coulton L, Shaughnessy JD Jr., Evans HR, et al. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. J Bone Min Res. 2009;24(3):425â€“36.</cite> [<a href="https://doi.org/10.1359/jbmr.081104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19016584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heath%20DJ,%20Chantry%20AD,%20Buckle%20CH,%20Coulton%20L,%20Shaughnessy%20JD%20Jr.,%20Evans%20HR,%20et%20al.%20Inhibiting%20Dickkopf-1%20(Dkk1)%20removes%20suppression%20of%20bone%20formation%20and%20prevents%20the%20development%20of%20osteolytic%20bone%20disease%20in%20multiple%20myeloma.%20J%20Bone%20Min%20Res.%202009;24(3):425%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Simic MK, Mohanty ST, Xiao Y, Cheng TL, Taylor VE, Charlat O et al. Multi-targeting DKK1 and LRP6 prevents bone loss and improves fracture resistance in multiple myeloma. J Bone Min Res. 2023;38(6):814-28. </cite> [<a href="https://doi.org/10.1002/jbmr.4809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10947379/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36987921/" class="usa-link">PubMed</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Yaccoby S, Ling W, Zhan F, Walker R, Barlogie B, Shaughnessy JD Jr. Antibody-based Inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood. 2007;109(5):2106â€“11.
</cite> [<a href="https://doi.org/10.1182/blood-2006-09-047712" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1801040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17068150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yaccoby%20S,%20Ling%20W,%20Zhan%20F,%20Walker%20R,%20Barlogie%20B,%20Shaughnessy%20JD%20Jr.%20Antibody-based%20Inhibition%20of%20DKK1%20suppresses%20tumor-induced%20bone%20resorption%20and%20multiple%20myeloma%20growth%20in%20vivo.%20Blood.%202007;109(5):2106%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372396/bin/40164_2025_699_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (2.4MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The sc-RNA-seq and bulk RNAseq data generated in this study were deposited in the NCBI SRA database under the Bioproject PRJNA1210176 and PRJNA1211159. All other raw data are available upon request from the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Experimental Hematology &amp; Oncology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40164-025-00699-4"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40164_2025_Article_699.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (9.3Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372396/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372396/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372396%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372396/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372396/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372396/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847323/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372396/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847323/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372396/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372396/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="P3Qj5DaNtsDY2g26DxigtyHL8MePWVIXXmN8awaRwU0969V3UPEN3fRYczEEMgwL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
